Limits of Negative Infection Studies in AD - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Limits of Negative Infection Studies in AD

Perspective argues that study design and measurement challenges may obscure potential links between infection and disease

  • By

  • Kerri Miller

  • March 26, 2026

  • 2 min

Share

  • 1

    Negative infection studies in Alzheimer's disease may misinterpret data due to poor alignment with research questions.

  • 2

    Serum antibody titers do not accurately reflect central nervous system infections, complicating study outcomes.

  • 3

    Electronic health records may overlook milder infections, leading to incomplete data on pathogen exposure.

  • 4

    Genetic factors, such as APOE ε4, may influence the relationship between pathogens and Alzheimer's risk.

  • 5

    The authors advocate for refined study designs that incorporate genetic context and infection dynamics.

Original Source(s)

Limits of Negative Infection Studies in AD

  • by Kerri Miller

  • March 26, 2026

Related Content

Handwriting Kinematics Differentiate Cognitive Impairment

“Diagnostic differentiation emerged only under tasks imposing higher cognitive-motor demands.”

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

Metabolic Health Tied to Dementia

In two population-based cohorts, metabolically unhealthy status generally showed higher dementia risk estimates, while metabolically healthy obesity was not associated with increased risk in primary analyses.